Abiopharma

🔍 Page Andrew E (Executive)

Company: Amer Sports, Inc. (AS)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 4,514 shares of Ordinary Shares (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 8,597.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,022 shares of Ordinary Shares at $28.63 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,575.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 4,514 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,028.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one Ordinary Share of Amer Sports, Inc.
• F2: Shares sold pursuant to a sell to cover transaction to satisfy tax withholding obligations upon the vesting of equity awards. The sales were executed automatically pursuant to a sell to cover arrangement and do not represent a discretionary trade by the Reporting Person.
• F3: Reflects restricted stock units granted under the Amer Sports, Inc. 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan") on September 1, 2025, which are scheduled to vest in equal installments on September 1, 2026, September 1, 2027 and September 1, 2028, subject to the terms of the 2024 Omnibus Plan and the applicable award agreement. These restricted stock units were previously incorrectly reported on the Reporting Person's Form 3 as having been granted on April 1, 2025.